Project description
Lowering treatment costs for brain disorders through AI
In healthcare, the cost of treating brain disorders accounts for a significant percentage of total treatment costs. In Europe, the budget for treating brain disorders alone far surpasses the combined budget for other diseases. Utilising cutting-edge AI, the EU-funded ALAMEDA project could greatly reduce the cost of treating these conditions by enabling personalised care and improved treatments for major brain disorders. The goal is to demonstrate AI-enabled prediction, prevention and intervention, making the treatment of disorders such as Parkinson's, multiple sclerosis and strokes more affordable and easing the burden on healthcare systems across Europe.
Fields of science
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
Participants (15)
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
060042 Bucharest
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
57001 Thermi Thessaloniki